https://ir.bioaffinitytech.com/news-events/press-releases/rss en-us https://s3.amazonaws.com/equisolve-dev4/bioaffinitytech/files/theme/images/logo-sm.png Equisolve Investor Relations Suite https://ir.bioaffinitytech.com/news-events/press-releases/detail/195/bioaffinity-technologies-announces-1-for-15-reverse-stock-split-effective-at-the-open-of-trading-on-august-24-2026 Thu, 20 Aug 26 08:00:00 -0400 https://ir.bioaffinitytech.com/news-events/press-releases/detail/195/bioaffinity-technologies-announces-1-for-15-reverse-stock-split-effective-at-the-open-of-trading-on-august-24-2026 https://ir.bioaffinitytech.com/news-events/press-releases/detail/194/bioaffinity-technologies-and-avmedical-announce-nationwide-federal-healthcare-distribution-agreement-for-cypath-lung Tue, 18 Aug 26 08:00:00 -0400 https://ir.bioaffinitytech.com/news-events/press-releases/detail/194/bioaffinity-technologies-and-avmedical-announce-nationwide-federal-healthcare-distribution-agreement-for-cypath-lung https://ir.bioaffinitytech.com/news-events/press-releases/detail/193/bioaffinity-technologies-announces-closing-of-4m-private-placement-offering-priced-at-the-market-under-nasdaq-rules Fri, 14 Aug 26 11:07:00 -0400 https://ir.bioaffinitytech.com/news-events/press-releases/detail/193/bioaffinity-technologies-announces-closing-of-4m-private-placement-offering-priced-at-the-market-under-nasdaq-rules https://ir.bioaffinitytech.com/news-events/press-releases/detail/192/bioaffinity-technologies-announces-pricing-of-4m-private-placement-offering-priced-at-the-market-under-nasdaq-rules Thu, 13 Aug 26 09:07:00 -0400 https://ir.bioaffinitytech.com/news-events/press-releases/detail/192/bioaffinity-technologies-announces-pricing-of-4m-private-placement-offering-priced-at-the-market-under-nasdaq-rules https://ir.bioaffinitytech.com/news-events/press-releases/detail/191/bioaffinity-technologies-reports-second-quarter-2026-results-and-continued-strong-commercial-momentum-for-cypath-lung Fri, 07 Aug 26 08:00:00 -0400 https://ir.bioaffinitytech.com/news-events/press-releases/detail/191/bioaffinity-technologies-reports-second-quarter-2026-results-and-continued-strong-commercial-momentum-for-cypath-lung https://ir.bioaffinitytech.com/news-events/press-releases/detail/190/bioaffinity-technologies-publishes-new-clinical-framework-addressing-growing-market-for-pulmonary-nodule-risk-stratification-and-early-lung-cancer-detection-using-cypath-lung Mon, 27 Jul 26 08:08:00 -0400 https://ir.bioaffinitytech.com/news-events/press-releases/detail/190/bioaffinity-technologies-publishes-new-clinical-framework-addressing-growing-market-for-pulmonary-nodule-risk-stratification-and-early-lung-cancer-detection-using-cypath-lung https://ir.bioaffinitytech.com/news-events/press-releases/detail/189/bioaffinity-technologies-and-pictor-inc-partner-to-develop-and-commercialize-bioaffinitys-diagnostics-for-asthma-and-copd Wed, 22 Jul 26 08:08:00 -0400 https://ir.bioaffinitytech.com/news-events/press-releases/detail/189/bioaffinity-technologies-and-pictor-inc-partner-to-develop-and-commercialize-bioaffinitys-diagnostics-for-asthma-and-copd https://ir.bioaffinitytech.com/news-events/press-releases/detail/188/bioaffinity-technologies-quarterly-cypath-lung-sales-double-to-new-record-as-commercial-momentum-continues Tue, 07 Jul 26 08:46:00 -0400 https://ir.bioaffinitytech.com/news-events/press-releases/detail/188/bioaffinity-technologies-quarterly-cypath-lung-sales-double-to-new-record-as-commercial-momentum-continues https://ir.bioaffinitytech.com/news-events/press-releases/detail/187/bioaffinity-technologies-reports-positive-preclinical-findings-showing-proprietary-gene-silencing-technology-is-selectively-cytotoxic-to-squamous-skin-cancer-cells-without-harming-healthy-cells Mon, 22 Jun 26 08:00:00 -0400 https://ir.bioaffinitytech.com/news-events/press-releases/detail/187/bioaffinity-technologies-reports-positive-preclinical-findings-showing-proprietary-gene-silencing-technology-is-selectively-cytotoxic-to-squamous-skin-cancer-cells-without-harming-healthy-cells https://ir.bioaffinitytech.com/news-events/press-releases/detail/186/bioaffinity-technologies-announces-closing-of-3-2-million-offering Thu, 18 Jun 26 13:16:00 -0400 https://ir.bioaffinitytech.com/news-events/press-releases/detail/186/bioaffinity-technologies-announces-closing-of-3-2-million-offering